Additional file 1: Table S1. of Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer

Abstract

The primer sequences used for PCR. (DOCX 15 kb

    Similar works

    Full text

    thumbnail-image

    Available Versions